Nina Frey, PhD

Scientist @Roche, PhD alumni from @SchwankLab #CRISPRScreening #GeneTherapy, passionate scientist, cook and handball player

[Nina Frey, PhD @nifrey7]

I am really happy to share my PhD work published today @NatureComms. Thanks to the entire @Schwanklab @UZH and our great collaborators from the Kopf Lab @ETHZ. Highlights in the thread below (1/13). Read entire story here: https://t.co/qktL7VWR7e

[David R. Liu @davidrliu]

Today in @ScienceMagazine we report the development of a laboratory-evolved CRISPR-associated transposase (evoCAST) that supports therapeutically relevant levels of RNA-programmable gene insertion in human cells, a collaboration with @SternbergLab.
1/13
https://t.co/ZLHtZm5Gmw

[Kim Fabiano Marquart @marquark]

🎙️Excited to launch my new podcast #CRISPRli, a deep dive into the revolutionary world of #CRISPR. I'll be hosting interviews with top genome editing experts. Ideal for scientists, students or anyone curious about this cutting-edge tech. #GeneEditing
https://t.co/cJR4KbjY14

[Nicolas Mathis @nicopmat]

Excited to see our study "Predicting prime editing efficiency and product purity by deep learning" published in @NatureBiotech today! @schwanklab @krauthammerlab https://t.co/JGAVSYJhfe 1/14

[Nina Frey, PhD @nifrey7]

@DontShowYourCat Hahaha katzen sind toll

[Nina Frey, PhD @nifrey7]

@TuncayBaubec Nice to see this out!! Congrats to the team!

[Nina Frey, PhD @nifrey7]

@TheSpenceLab @UMCDB @ReneeConway @joshhwu @tristanfrum @_Alyssa_J_ @Dev_Cell That’s a cool story and I love the images!! Congrats to the team and @ReneeConway

[Nature Communications @NatureComms]

Rnf31 and Vps4b promote pancreatic cancer resistance to T cell-mediated killing: therapeutic implications.
https://t.co/lMwrrFQPhg
#CancerResearch @natrescancer

[Human Immunology News @humanimmunenews]

The @SchwankLab at @UZH_en, led by Dr. Nina Frey (@nifrey7), identified Vps4b and Rnf31 as essential factors required for escaping #CD8+ T cell killing, uncovering vulnerabilities in pancreatic ductal adenocarcinoma.

Read more: 📌 https://t.co/9P9sS0J7NX

[Gerald Schwank @schwanklab]

Big congrats to @nifrey7 on her CRISPR immune evasion screen in PDAC. Read her fantastic thread to learn more about her findings!

[Nina Frey, PhD @nifrey7]

@tanjarothgangl Danke Tanja!!! 😍

[Nina Frey, PhD @nifrey7]

Thanks again to the amazing @schwanklab and especially to @tanjarothgangl, @marquark, @sharan_janjuha and all others that made this project possible and for the great time I spent there as a PhD student. 13/13

[Nina Frey, PhD @nifrey7]

I am really happy to share my PhD work published today @NatureComms. Thanks to the entire @Schwanklab @UZH and our great collaborators from the Kopf Lab @ETHZ. Highlights in the thread below (1/13). Read entire story here: https://t.co/qktL7VWR7e

[Nina Frey, PhD @nifrey7]

Altogether our work shows that PDA shares core pathways that sensitize tumors to T-cell mediated killing. In addition, we describe in detail two possible targets, Vps4b and Rnf31, that specifically increase tumor cell clearance and immunotherapy efficacy upon depletion. 12/